The Kyolic garlic supplement maker is launching a new line of dietary supplements including Echinacea-Go!, Ginseng-Go!, St. John's Wort-Go! and Una De Gato-Go! The one-per-day capsules will be sold in most outlets that carry the Kyolic brand. Suggested retail prices range from $9.99 for a 60-count bottle of the St. John's wort product to $24.99 for the 60-count yeast, sodium and dairy-free ginseng extract product. No ads are planned for the new line. Mission Viejo, Calif.-based Wakunaga of America is one of the first NNFA member companies to be certified under the association's new GMP program (1see story, p. 16)
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
If US tariffs on pharmaceutical supply chain products come into force they could be disruptive for companies. Ewan Townsend, of the international law firm Arnold & Porter, explains how companies can mitigate issues through negotiating with suppliers and reallocating tariff responsibilities.
With European biosimilars developers buoyed by recent regulatory moves, Medicines for Europe’s Isabell Remus and Julie Maréchal-Jamil discuss the next steps forward for the industry.
